• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL EPIC MAX VALVE (AORTIC); HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL EPIC MAX VALVE (AORTIC); HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Catalog Number EMAX-21
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problem Obstruction/Occlusion (2422)
Event Date 02/09/2024
Event Type  Death  
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
It was reported that on (b)(6) 2024, a 21mm epic max valve was chosen for implant in a 77-year-old woman.During the procedure, it was noted that the corresponding 21mm epic max replica end of the sizer was difficult to pass through the sinotubular junction (stj) and in the process of forcing the sizer through the stj there was an injury caused to the aorta.Despite the difficulties in passing the 21mm epic max replica end of the sizer through the stj the physician decided to implant an epic max 21mm valve.The physician had difficulty seating the epic max 21mm valve on top of the annulus and had to patch the aorta to fit the valve.When the patient was taken off cardiopulmonary bypass, there were concerns about a blocked right coronary artery, so a saphenous vein graft was taken and bypassed to the right coronary artery.There continued to be difficulty separating from cardiopulmonary bypass so an internal mammary artery was taken and bypassed to the left anterior descending (lad) coronary artery.The patient continued to have difficulty separating from cardiopulmonary bypass, so she was placed on extracorporeal membrane oxygenation (ecmo) and transferred to cardiovascular intensive care unit (cvicu).However, several days later the patient passed away.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EPIC MAX VALVE (AORTIC)
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT MEDICAL REG#3007113487
177 county road b east
st. paul MN 55117 1789
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key18852506
MDR Text Key337067729
Report Number2135147-2024-01029
Device Sequence Number1
Product Code LWR
UDI-Device Identifier05415067045447
UDI-Public05415067045447
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 03/06/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/06/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberEMAX-21
Device Lot NumberBR00040205
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/09/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/23/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age77 YR
Patient SexFemale
-
-